Amélie Lothe, PhD, discusses findings showing early, sustained benefits of fenfluramine treatment for patients with Lennox-Gastaut syndrome.
|Articles|October 7, 2006
It's a jungle out there: Help keep your patients safe from outdoor animal and weather hazards!
Playing outside is a long-held joy of childhood, but bugs and animals that can cause harm lurk in places where children are likely to be playing?including the lawn, the woods, and the playground. Dennis L. Murray, MD, professor of pediatrics at the Medical College of Georgia in Augusta, offered preventive advice that you can share with parents during a seminar, "Keeping Children Safe in the Great Outdoors" Saturday at the 2006 AAP National Conference and Exhibition in Atlanta.
Advertisement
Advertisement
Related to this article
FDA approved levacetylleucine (Aqneursa) for ataxia in ataxia-telangiectasia, the first therapy for the disease, in patients 15 kg or heavier.
Tallie Z. Baram, MD, talks about how adding a measure of childhood unpredictability to ACEs screening may help pediatricians identify children at risk for mental health problems.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
The FDA granted priority review to efzimfotase alfa for HPP in patients aged 2 years and older; a decision is expected in the first half of 2027.
Adolescent VALIANT subgroup data show pegcetacoplan cut proteinuria 75% vs placebo, supporting its expanded pediatric kidney indication.
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf), a one-time AAV9 gene therapy, as the first treatment for pediatric MPS IIIA (Sanfilippo syndrome type A).
Aquestive resubmitted its NDA for dibutepinephrine sublingual film Anaphylm, citing new human factors and PK data addressing the FDA's CRL.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Updated AAP guidance changes iron deficiency screening and treatment in children
2
FDA grants priority review to efzimfotase alfa for hypophosphatasia in patients aged 2 years and older
3
FDA approves levacetylleucine as first treatment for ataxia in ataxia-telangiectasia
4
Fenfluramine shows sustained seizure reduction, functional improvement in Lennox-Gastaut syndrome
5